SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT
Provided By PR Newswire
Last update: Jul 18, 2025
LOS ANGELES, July 18, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ: SRPT) for violations of the federal securities laws.
Read more at prnewswire.com13.32
-0.75 (-5.36%)
Find more stocks in the Stock Screener
SRPT Latest News and Analysis
